1. Home
  2. ATLX vs RANI Comparison

ATLX vs RANI Comparison

Compare ATLX & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlas Lithium Corporation

ATLX

Atlas Lithium Corporation

HOLD

Current Price

$2.91

Market Cap

91.2M

Sector

Industrials

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.85

Market Cap

106.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLX
RANI
Founded
2011
2012
Country
Brazil
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.2M
106.9M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
ATLX
RANI
Price
$2.91
$0.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$12.00
$7.50
AVG Volume (30 Days)
186.3K
509.8K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
47.08
57.14
EPS
N/A
N/A
Revenue
$92,491.00
$1,633,000.00
Revenue This Year
$64,564.67
$274.77
Revenue Next Year
$785.59
$79.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
58.85
52 Week Low
$2.55
$0.45
52 Week High
$8.25
$3.87

Technical Indicators

Market Signals
Indicator
ATLX
RANI
Relative Strength Index (RSI) 36.62 51.37
Support Level $2.74 $0.73
Resistance Level $3.45 $0.92
Average True Range (ATR) 0.13 0.05
MACD -0.05 -0.00
Stochastic Oscillator 3.74 59.84

Price Performance

Historical Comparison
ATLX
RANI

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project, located in Minas Gerais State in Brazil. The company is focused on producing and selling lithium concentrate, a key ingredient for the battery supply chain.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: